Advance Search
YANG Chengying, WEI Ting, PAN Min, ZENG Di. Research progress on perioperative nursing for radiofrequency ablation of atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 115-119. DOI: 10.7619/jcmp.20200970
Citation: YANG Chengying, WEI Ting, PAN Min, ZENG Di. Research progress on perioperative nursing for radiofrequency ablation of atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 115-119. DOI: 10.7619/jcmp.20200970
shu

Research progress on perioperative nursing for radiofrequency ablation of atrial fibrillation

  • Department of Cardiology, Tangdu Hospital of Air Force Military Medical University of Chinese People′s Liberation Army, Xi′an, Shaanxi, 710038

More Information
  • Received Date: September 25, 2020
  • Available Online: March 03, 2021
  • Published Date: March 03, 2021
    Graphical Abstract
    • Abstract
  • Rhythm control is an important part of the clinical treatment for atrial fibrillation, and the effectiveness of drugs to maintain rhythm control is low in the past. At present, radiofrequency ablation of atrial fibrillation based on circumferential pulmonary vein isolation has become the main scheme, so the standardized perioperative nursing for patients with atrial fibrillation can directly affect the effect of surgical treatment. This study retrospectively analyzed the nursing data of patients with atrial fibrillation treated by radiofrequency ablation in recent 5 years, and discussed the perioperative nursing strategies to ensure the success rate of radiofrequency ablation and reduce the incidence of complications.
    • FullText(HTML)
    • References (33)
  • [1]
    ODUTAYO A, WONGW C X, HSIAO A J, et al. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis[J]. BMJ, 2016, 354: i4482. http://www.ncbi.nlm.nih.gov/pubmed/27599725
    [2]
    MORIN D P, BERNARD M L, MADIAS M L, et al. The State of the Art: Atrial Fibrillation Epidemiology, Prevention, and Treatment[J]. Mayo Clin Proc, 2016, 91(12): 1778-1810. doi: 10.1016/j.mayocp.2016.08.022
    [3]
    AMJAD W, QURESHI W, FAROOQ A, et al. Gastrointestinal Side Effects of Antiarrhythmic Medications: A Review of Current Literature[J]. Cureus, 2017, 9(9): e1646. http://europepmc.org/articles/PMC5669531/
    [4]
    SARDAR M R, SAEED W, KOWEY P R. Antiarrhythmic Drug Therapy for Atrial Fibrillation[J]. Heart Fail Clin, 2016, 12(2): 205-221. doi: 10.1016/j.hfc.2015.08.017
    [5]
    RAATIKAINEN M J, HAKALAHTI A, UUSIMAA P, et al. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial[J]. Int J Cardiol, 2015, 198: 108-114. doi: 10.1016/j.ijcard.2015.06.160
    [6]
    HONG K L, BORGES J, GLOVER B. Catheter ablation for the management of atrial fibrillation: current technical perspectives[J]. Open Heart, 2020, 7(1): e001207. doi: 10.1136/openhrt-2019-001207
    [7]
    HAKALAHTI A, BIANCARI F, NIELSEN JC, et al. Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis[J]. Europace, 2015, 17(3): 370-378. doi: 10.1093/europace/euu376
    [8]
    TAKAHASHI Y, O'NEILL MD, HOCINI M, et al. Effects of stepwise ablation of chronic atrial fibrillation on atrial electrical and mechanical properties[J]. J Am Coll Cardiol, 2007, 49: 1306-1314. doi: 10.1016/j.jacc.2006.11.033
    [9]
    KATRITSIS D G, POKUSHALOV E, ROMANOV A, et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial[J]. J Am Coll Cardiol, 2013, 62: 2318-2325. doi: 10.1016/j.jacc.2013.06.053
    [10]
    GARREY W E. The nature of fibrillary contraction of the heart: its relation to tissue mass and form[J]. Am J Physiol, 2014; 33: 397-414.
    [11]
    HAISSAGUERRE M, JAIS P, SHAH D C, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins[J]. N Engl J Med, 1998, 339: 659-666. doi: 10.1056/NEJM199809033391003
    [12]
    NARAYAN S M, KRUMMEN D E, SHIVKUMAR K, et al. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial[J]. J Am Coll Cardiol, 2012, 60: 626-636. doi: 10.1016/j.jacc.2012.01.069
    [13]
    COX J L, SCHUESSLER R B, D'AGOSTINO HJ Jr, et al. The surgical treatment of atrial fibrillation. Ⅲ. Development of a definitive surgical procedure[J]. J Thorac Cardiovasc Surg, 1991, 101: 569-583. doi: 10.1016/S0022-5223(19)36684-X
    [14]
    JOSE M SANCHEZ, GHANNAM Al-DOSARI, SHERMAN CHU, et al. Hybrid and surgical procedures for the treatment of persistent and longstanding persistent atrial fibrillation[J]. Expert Review of Cardiovascular Therapy, 2018, 16(2): 91-97. doi: 10.1080/14779072.2018.1425140
    [15]
    CHENITI G, VLACHOS K, PAMBRUN T, et al. Atrial Fibrillation Mechanisms and Implications for Catheter Ablation[J]. Front Physiol, 2018, 9: 1458. doi: 10.3389/fphys.2018.01458
    [16]
    ZHENG L, YAO Y, ZHANG S, et al. Organized left atrial tachyarrhythmia during stepwise linear ablation for atrial fibrillation[J]. J Cardiovasc Electrophysiol, 2009, 20: 499-506. doi: 10.1111/j.1540-8167.2008.01371.x
    [17]
    FIALA M. Catheter Ablation for Persistent and Long-Standing Persistent Atrial Fibrillation[J]. J Atr Fibrillation, 2016, 9(3): 1473-1473. doi: 10.4022/jafib.1473
    [18]
    NADEMANEE K, MCKENZIE J, KOSAR E, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate[J]. J Am Coll Cardiol, 2004, 43: 2044-2053. doi: 10.1016/j.jacc.2003.12.054
    [19]
    LEMOLA K, CHARTIER D, YEH Y H, et al. Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia[J]. Circulation. 2008; 117(4): 470-477. doi: 10.1161/CIRCULATIONAHA.107.737023
    [20]
    贾琴, 郑明霞, 何森. 围术期优质护理在射频消融术治疗阵发性房颤中的应用效果[J]. 中国医药导报, 2018, 15(22): 157-160. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201822040.htm
    [21]
    荆晓霞, 杨爽, 于芳芳, 等. 34例行射频消融术治疗房颤患者的围术期护理体会[J]. 中国现代药物应用, 2019, 13(20): 151-152. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWYY201920093.htm
    [22]
    GURSOY A, CANDAS B, GUNER Ş, et al. Preoperative Stress: An Operating Room Nurse Intervention Assessment[J]. J Perianesth Nurs, 2016, 31(6): 495-503. doi: 10.1016/j.jopan.2015.08.011
    [23]
    王杰. 房颤射频消融术患者围手术期护理对策及效果观察[J]. 中国城乡企业卫生, 2020, 35(1): 208-209. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCXW202001095.htm
    [24]
    CAPPATO R, CALKINS H, CHEN S A, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation[J]. Circ Arrhythm Electrophysiol, 2010, 3(1): 32-38. doi: 10.1161/CIRCEP.109.859116
    [25]
    GARG L, GARG J, GUPTA N, et al. Gastrointestinal complications associated with catheter ablation for atrial fibrillation[J]. Int J Cardiol, 2016, 224: 424-430. doi: 10.1016/j.ijcard.2016.09.069
    [26]
    POULSEN J L, BROCK C, OLESEN E, et al. Evolving paradigms in the treatment of opioid-induced bowel dysfunction[J]. Therap Adv Gastroenterol, 2015, 8(6): 360-372. doi: 10.1177/1756283X15589526
    [27]
    FARMER A D, HOLT C B, DOWNES T J, et al. Pathophysiology, diagnosis, and management of opioid-induced constipation[J]. Lancet Gastroenterol Hepatol, 2018, 3(3): 203-212. doi: 10.1016/S2468-1253(18)30008-6
    [28]
    MATTIA A, NEWMAN J, MANETTA F. Treatment Complications of Atrial Fibrillation and Their Management[J]. Int J Angiol, 2020, 29(2): 98-107. doi: 10.1055/s-0039-3401794
    [29]
    SORGENTE A, CAPPATO R. Complications of catheter ablation: incidence, diagnosis and clinical management[J]. Komplikationen der Katheterablation-Inzidenz, Diagnostik und klinisches Management[J]. Herzschrittmacherther Elektrophysiol, 2019, 30(4): 363-370.
    [30]
    LAN L, ZENG Y, WANG WR, et al. Clinical characteristics and risk factors of pericardial effusion complicating radiofrequency catheter ablation in Chinese Han patients with tachyarrhythmias[J]. Herz, 2013, 38(8): 909-914. doi: 10.1007/s00059-013-3762-x
    [31]
    HAMAYA R, MIYAZAKI S, TANIGUCHI H, et al. Management of cardiac tamponade in catheter ablation of atrial fibrillation: single-centre 15 year experience on 5222 procedures[J]. Europace, 2018, 20(11): 1776-1782. doi: 10.1093/europace/eux307
    [32]
    LI C Y, LI SN, JIANG C Y, et al. Atrioesophageal fistula post atrial fibrillation ablation: A multicenter study from China[J]. Pacing Clin Electrophysiol, 2020, 10: 13973. doi: 10.1111/pace.13973
    [33]
    MITCHELL-BROWN F, MCPHERRIN M. Radiofrequency ablation-induced esophageal perforation[J]. Nursing, 2018, 48(10): 58-62. doi: 10.1097/01.NURSE.0000545019.91166.17
    • Related Articles

  • Related Articles

    [1]WU Nan, ZHENG Miaomiao, WANG Xinzhe, ZHU Xiang, TANG Hao. Research progress of protein arginine methyltransferase regulating bone formation and bone healing[J]. Journal of Clinical Medicine in Practice, 2024, 28(5): 126-129, 134. DOI: 10.7619/jcmp.20233520
    [2]HUANG Wei, WANG Xu, SHEN Zhimei, CUI Fei. Research progress on mechanism of action of stromal cell derived factor-1 in osteoporosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 144-148. DOI: 10.7619/jcmp.20222400
    [3]SHEN Qin, ZHU Hong, CHEN Luyuan. Effects of LncRNA NEF on differentiation and expression of related proteins of osteoblasts and osteoclasts[J]. Journal of Clinical Medicine in Practice, 2022, 26(20): 10-15, 22. DOI: 10.7619/jcmp.20220630
    [4]DONG Hui, YU Hang, WANG Yongxiang. Research progress in role and mechanism of circular RNA in osteoporosis[J]. Journal of Clinical Medicine in Practice, 2021, 25(4): 111-115. DOI: 10.7619/jcmp.20210167
    [5]LI Hongda, WU Hualong, WU Shuangshi, ZHAO Jiwei, SUN Hao, HU Le, WANG Yongxiang. Research on screening of serum differential proteins in patients with osteoporosis by iTRAQ technology[J]. Journal of Clinical Medicine in Practice, 2020, 24(21): 97-101. DOI: 10.7619/jcmp.202021028
    [6]ZHANG hai-yan, LIU qi, YANG jun-hai. Attachment and proliferation of alveolar bone cells to diseased root surfaces treated with platelet- poor plasma and demineralization in vitro[J]. Journal of Clinical Medicine in Practice, 2011, (21): 33-36. DOI: 10.3969/j.issn.1672-2353.2011.21.011
    [7]ZHEN Peng-fei, DONG Zhan, WANG Jie-guo, LOU Yao. Thyrocalcitonin regulates the cbfa1mRNA expression of osteoblasts via signal pathway of ERK-MAPK[J]. Journal of Clinical Medicine in Practice, 2009, (7): 35-38. DOI: 10.3969/j.issn.1672-2353.2009.07.009
    [9]ZHAO Ji-dong, ZHU Jian-zhong, MIAO Zong-lin, QIAN Han-guang, PENG Wei. THE EXPERIMENT STUDY OF THE DIFFERENTIATION OF BONE MARROW MESENCHMAL STEM CELLS TO EXPRESS THE PHENOTYPE OF CHONDROCYTE LINEAGEBY TRANSFORMING GROWTH FACTOR-β3 IN VITRO[J]. Journal of Clinical Medicine in Practice, 2005, (11): 45-48. DOI: 10.3969/j.issn.1672-2353.2005.11.013
    [10]EXPERIMENTAL STUDY OF OSTEOBLASTS FROM HUMAN BONE MARROW COCULTURE WITH THE NANOMETER MATERIAL[J]. Journal of Clinical Medicine in Practice, 2003, (3): 212-214. DOI: 10.3969/j.issn.1672-2353.2003.03.008

Catalog

    Get Citation
    PDF
    XML
    Article views (324) PDF downloads (26) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return